TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31603868

Group type: EXPERIMENTAL
Intervention: Short education session about the risks of untreated hypertension
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (no education session)
Number of subjects: 600
Study: 28109665

Group type: EXPERIMENTAL
Intervention: Low-dose olanzapine (5mg/day) plus low-dose trifluoperazine (5mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-dose olanzapine (10mg/day)
Number of subjects: 0
Study: 26812974

Group type: EXPERIMENTAL
Intervention: Pulmonary ultrasound guidance
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (bedside chest X-ray)
Number of subjects: 100
Study: 23453367

Group type: EXPERIMENTAL
Intervention: Cast immobilization using Quickcast(®) (QC)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Removable, lever-type thermoplastic orthosis (LTTP)
Number of subjects: 57
Study: 21203366

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 174
Study: 20467642

Group type: EXPERIMENTAL
Intervention: Immediate loading
Number of subjects: 60

Group type: COMPARATOR
Intervention: Early loading
Number of subjects: 60
Study: 17533704

Group type: EXPERIMENTAL
Intervention: Self-etching system (Adper and Prompt, 3M‐ESPE)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Phosphate acid system
Number of subjects: 62
Study: 14579790

Group type: EXPERIMENTAL
Intervention: Laser needle stimulation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Laser needle acupuncture
Number of subjects: 22
Study: 10861324

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 136

Group type: COMPARATOR
Intervention: Randomized, controlled trials
Number of subjects: 136
Study: 8987323

Group type: EXPERIMENTAL
Intervention: 2 g of oral elemental calcium per day (n = 103)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo (n = 98)
Number of subjects: 201
Study: 1639618

Group type: EXPERIMENTAL
Intervention: Levodopa, administered daily for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous study with a single dose of levodopa
Number of subjects: 0
Study: 6712450

Group type: EXPERIMENTAL
Intervention: Active bilateral full‐range forearm flexion and extension movements (60 movements per minute) during the first and third minute of each tilt angle
Number of subjects: 12

Group type: COMPARATOR
Intervention: No upper limb exercises
Number of subjects: 12
Study: 30819827

Group type: EXPERIMENTAL
Intervention: MNC-developed ICIs
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Domestic-developed ICIs
Number of subjects: 26
Study: 30144159

Group type: EXPERIMENTAL
Intervention: Complete digital workflows (test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combined analog‐digital workflows (control)
Number of subjects: 20
Study: 27424128

Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg
Number of subjects: 0
Study: 23937297

Group type: EXPERIMENTAL
Intervention: Experimental group received 2 individualized feedback sessions regarding safety and productivity-related issues in daily verbal exchanges.
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group received no feedback.
Number of subjects: 7
Study: 22710946

Group type: EXPERIMENTAL
Intervention: VaPro catheter
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 106
Study: 20013018

Group type: EXPERIMENTAL
Intervention: Functional end-to-end anastomosis using a linear stapler
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional ileostomy takedown
Number of subjects: 119
Study: 18686768

Group type: EXPERIMENTAL
Intervention: Root debridement with Gracey curettes and root brushing with 40% tetracycline gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Root debridement with Gracey curettes and root brushing with saline solution
Number of subjects: 20
Study: 16414910

Group type: EXPERIMENTAL
Intervention: H2460 dressing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Flexzan dressing
Number of subjects: 10
Study: 12560019

Group type: EXPERIMENTAL
Intervention: Engaged with the intervention (defined as finding it useful and interesting)
Number of subjects: 8352

Group type: EXPERIMENTAL
Intervention: Disengaged from the intervention (not finding it useful or interesting)
Number of subjects: 8352
Study: 9792282

Group type: EXPERIMENTAL
Intervention: Major surgery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non-operated control group
Number of subjects: 23
Study: 7836084

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy and CMF chemotherapy simultaneously
Number of subjects: 138

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Simultaneous radiation therapy and chemotherapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 138
Study: 2403061

Group type: EXPERIMENTAL
Intervention: Intravenous maltose infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous glucose infusion
Number of subjects: 0
Study: 319326

Group type: EXPERIMENTAL
Intervention: Physical training (6-week period)
Number of subjects: 0
Study: 30860417

Group type: EXPERIMENTAL
Intervention: Self-myofascial release with movement of the pectoralis minor
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (minimal pressure applied to the xiphoid process)
Number of subjects: 21
Study: 29902020

Group type: EXPERIMENTAL
Intervention: Still Climbin' intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 64
Study: 29122260

Group type: EXPERIMENTAL
Intervention: Olfactory mental imagery (experimental group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study: 26337603

Group type: EXPERIMENTAL
Intervention: Medical marijuana
Number of subjects: 868

Group type: COMPARATOR
Intervention: Recreational marijuana
Number of subjects: 868
Study: 24072234

Group type: EXPERIMENTAL
Intervention: B-ultrasound-guided IHP with 48 °C distilled water (DW)
Number of subjects: 23

Group type: COMPARATOR
Intervention: B-ultrasound-guided IHP with 45 °C physiological saline solution and cisplatin (PSS-C)
Number of subjects: 23
Study: 21138775

Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during voluntary breathing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during static inspiratory effort
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during involuntary ventilation
Number of subjects: 10
Study: 18500156

Group type: EXPERIMENTAL
Intervention: elmex SENSITIVE toothbrush
Number of subjects: 107

Group type: COMPARATOR
Intervention: ADA reference brush
Number of subjects: 107
Study: 16594930

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menatetrenone) 45 mg and calcium carbonate 1500 mg per day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo and calcium carbonate 1500 mg per day
Number of subjects: 63
Study: 12690583

Group type: EXPERIMENTAL
Intervention: Robotic therapy (3 times weekly for 6 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Progressive‐resistive robotic therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sensorimotor robotic therapy
Number of subjects: 20
Study: 11189800

Group type: EXPERIMENTAL
Intervention: Augmented care
Number of subjects: 619

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 619

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 619
Study: 9661615

Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 1 microgram/kg.day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 2 micrograms/kg.day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 4 micrograms/kg.day
Number of subjects: 20
Study: 8001357

Group type: EXPERIMENTAL
Intervention: Vaccine for the prevention of haemophilus influenzae type b
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prior probability distribution of vaccine efficacy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probability of regulatory approval for widespread use of the vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal stopping policy
Number of subjects: 0
Study: 3390997

Group type: EXPERIMENTAL
Intervention: gallopamil 37.5 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: gallopamil 50 mg t.i.d.
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 8256213

Group type: COMPARATOR
Intervention: Levothyroxine at substitutive dosage (100 micrograms)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levothyroxine at suppressive dosage (2.2 to 3 micrograms/kg/day)
Number of subjects: 60
Study: 356724

Group type: EXPERIMENTAL
Intervention: Cefamandole (1 g every 6 h)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Penicillin (600,000 U every 6 h)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 100

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 100
Study: 31339594

Group type: EXPERIMENTAL
Intervention: Sarpogrelate with high-dose statin (Group A, n = 25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sarpogrelate with low-dose or no statin (Group B, n = 25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with high-dose statin (Group C, n = 25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with low-dose or no statin (Group D, n = 25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose statin (compared to low-dose or no statin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Distal TIMI flow on initial provocation test
Number of subjects: 100
Study: 28024770

Group type: EXPERIMENTAL
Intervention: Indirect bonding group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Direct bonding group
Number of subjects: 64
Study: 25651203

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with partial tenonectomy (group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Trabeculectomy alone (group B)
Number of subjects: 46
Study: 24773263

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 42
Study: 21946012

Group type: EXPERIMENTAL
Intervention: General mental imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-referential mental imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basic visual imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex types of imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Episodic memory deficits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intact basic mental imagery and rehearsal
Number of subjects: 0
Study: 19569965

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01B
Number of subjects: 102

Group type: COMPARATOR
Intervention: RTS,S/AS02A
Number of subjects: 102
Study: 17289576

Group type: EXPERIMENTAL
Intervention: Bromocriptine, an inhibitor of prolactin secretion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forced myocardial generation of 16 kDa prolactin
Number of subjects: 0

Group type: COMPARATOR
Intervention: PPCM patients
Number of subjects: 0
Study: 15356502

Group type: EXPERIMENTAL
Intervention: Maxillary occlusal splints
Number of subjects: 16

Group type: COMPARATOR
Intervention: No splints (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chewing‐like movement
Number of subjects: 16
Study: 12195694

Group type: EXPERIMENTAL
Intervention: B-vitamin supplements (5 mg folic acid, 0.4 mg hydroxycobalamin, and 50 mg pyridoxine) daily for 8 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: B-vitamin supplements
Number of subjects: 118
Study: 9894361

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0
Study: 8017326

Group type: EXPERIMENTAL
Intervention: Flaxseed powder (10 g/d)
Number of subjects: 18
Study: 2808261

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) at a mean maximal daily oral dose of 4.6 +/- 0.2 mg/kg for 6 weeks.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) for 6 additional weeks in 27 placebo nonresponders.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: DMI treatment above 3.5 mg/kg.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 58
Study: 1096927

Group type: EXPERIMENTAL
Intervention: 3 g ascorbic acid daily
Number of subjects: 8
Study: 30813776

Group type: EXPERIMENTAL
Intervention: Botulinum toxin and serial casting
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Splinting and motor training following serial casting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (wait list for six weeks)
Number of subjects: 10
Study: 28711114

Group type: EXPERIMENTAL
Intervention: Explicit ABM training protocol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Implicit ABM training protocol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Implicit-Explicit ABM training protocol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All training protocols
Number of subjects: 45
Study: 27533964

Group type: EXPERIMENTAL
Intervention: Mangafodipir (MnDPDP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 23498759

Group type: EXPERIMENTAL
Intervention: Infra-low-frequency transcranial magnetic stimulation (in addition to conventional comprehensive rehabilitation therapy)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional comprehensive rehabilitation therapy
Number of subjects: 75
Study: 21332798

Group type: EXPERIMENTAL
Intervention: Probiotic combination plus pre-biotics
Number of subjects: 1018

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1018
Study: 18250112

Group type: EXPERIMENTAL
Intervention: Benzbromarone 200 mg/day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Probenecid 2 g/day
Number of subjects: 62
Study: 16721856

Group type: EXPERIMENTAL
Intervention: Prednisolone plus Interferon
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interferon alone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Untreated children
Number of subjects: 48
Study: 15164330

Group type: EXPERIMENTAL
Intervention: Acipimox (500 mg orally at 2 am and again at 6 am)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10676671

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Diuretic agents
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Untreated group
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Sublingual NTG
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: NG‐monomethyl‐L‐arginine (NO synthase inhibitor)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Normotensive subjects (Control)
Number of subjects: 296
Study: 9354513

Group type: EXPERIMENTAL
Intervention: Fibrin glue sprayed on the 'raw' lung surface
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no fibrin glue)
Number of subjects: 66
Study: 1488570

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil (10 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no gallopamil)
Number of subjects: 8
Study: 3003883

Group type: EXPERIMENTAL
Intervention: High-fiber diet
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-fiber diet
Number of subjects: 80
Study: 31688396

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 30338820

Group type: EXPERIMENTAL
Intervention: TGF‐beta1
Number of subjects: 3

Group type: COMPARATOR
Intervention: High glucose
Number of subjects: 3
Study: 28835359

Group type: EXPERIMENTAL
Intervention: Maternal antibodies against malaria vaccine candidate antigens
Number of subjects: 33

Group type: COMPARATOR
Intervention: Mothers with placental malaria
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Vaccination of mothers with malaria vaccine during pregnancy
Number of subjects: 33
Study: 25642909

Group type: EXPERIMENTAL
Intervention: SonixGPS ultrasound needle guidance system activated
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional ultrasound (control group)
Number of subjects: 26
Study: 23902797

Group type: EXPERIMENTAL
Intervention: Self-directed intervention (adjunct motivational and autonomy-enhancing approach)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Prescribed intervention (standard prescription of uniform behavioral skills use and interventionist goal assignment)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Self-directed intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Prescribed intervention
Number of subjects: 72
Study: 20430503

Group type: EXPERIMENTAL
Intervention: knowledge-contact program
Number of subjects: 89

Group type: COMPARATOR
Intervention: knowledge program
Number of subjects: 89
Study: 18253904

Group type: EXPERIMENTAL
Intervention: Open access colonoscopy with trainee participation
Number of subjects: 368

Group type: COMPARATOR
Intervention: Open access colonoscopy without trainee participation
Number of subjects: 368
Study: 16959744

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 281

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass surgery
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control group (112 volunteers not undergoing surgery)
Number of subjects: 281
Study: 12840090

Group type: EXPERIMENTAL
Intervention: Azathioprine (2 mg per kilogram per day)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Cyclophosphamide (1.5 mg per kilogram of body weight per day)
Number of subjects: 155
Study: 10373765

Group type: EXPERIMENTAL
Intervention: Psychodynamically oriented treatment, median duration of therapy approximately 11 weeks.
Number of subjects: 1171

Group type: EXPERIMENTAL
Intervention: Psychodynamically oriented treatment
Number of subjects: 1171
Study: 8712092

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Bicalutamide 80 mg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Bicalutamide 100 mg
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study: 1714270

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 498

Group type: COMPARATOR
Intervention: Untreated eyes (Control)
Number of subjects: 498
Study: 7332916

Group type: EXPERIMENTAL
Intervention: Flubendazole, 100 mg twice a day for three days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mebendazole, 100 mg twice a day for three days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Flubendazole and Mebendazole
Number of subjects: 40
Study: 31037733

Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing intervention (6 sessions)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing intervention
Number of subjects: 90
Study: 28867499

Group type: EXPERIMENTAL
Intervention: Bictegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg
Number of subjects: 657

Group type: COMPARATOR
Intervention: Dolutegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg
Number of subjects: 657
Study: 27004302

Group type: EXPERIMENTAL
Intervention: Post-Discharge Formula (PDF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-Protein, Medium-Chain Triglyceride Containing Formula (HPMCT)
Number of subjects: 20
Study: 23490572

Group type: EXPERIMENTAL
Intervention: Web-delivered brief alcohol intervention (BAI) plus treatment as usual (TAU)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 167
Study: 21488763

Group type: EXPERIMENTAL
Intervention: Surveillance for MRSA and VRE colonization and expanded use of barrier precautions in intervention ICUs.
Number of subjects: 5434

Group type: COMPARATOR
Intervention: Existing practice in control ICUs.
Number of subjects: 5434
Study: 19833610

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mononuclear bone marrow cells (mBMCs), n=50
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no mBMCs), n=50
Number of subjects: 100
Study: 16540613

Group type: EXPERIMENTAL
Intervention: Paroxetine and psychotherapy
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Paroxetine and clinical-management sessions
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo and psychotherapy
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo and clinical-management sessions
Number of subjects: 116
Study: 12620292

Group type: EXPERIMENTAL
Intervention: IFN alpha‐2c (3.5 MU/d) plus araC (10 mg/m(2) d1‐10)
Number of subjects: 114

Group type: COMPARATOR
Intervention: IFN alpha‐2c (3.5 MU/d) plus hydroxyurea (HU: 25 mg/kg per day)
Number of subjects: 114
Study: 11095473

Group type: EXPERIMENTAL
Intervention: Continuous GH infusion (2 IU/m2-24 h)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Pulsatile GH administration (eight bolus injections)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both continuous and pulsatile GH administration
Number of subjects: 5
Study: 8143950

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 70
Study: 3510458

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and 0.6 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pentazocine 30 mg and 60 mg
Number of subjects: 100
Study: 30572423

Group type: EXPERIMENTAL
Intervention: Tamoxifen use (ever use)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Never use of tamoxifen
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Chronic kidney disease
Number of subjects: 281
Study: 25753488

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg daily
Number of subjects: 306

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 306
Study: 25035172

Group type: EXPERIMENTAL
Intervention: First-line response by receiving agencies classified into 3 categories: plan for action only, some action taken, and no plan and no action taken.
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Referral of children based on predefined criteria for violence disclosure.
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Help seeking behavior of children prior to the baseline survey.
Number of subjects: 3706